← Back to headlines
Rothschild Redburn Initiates Buy Ratings for Natera and Guardant Health
Investment bank Rothschild Redburn has initiated coverage of genetic testing firms Natera and Guardant Health, assigning buy ratings to both stocks. Analysts highlighted the companies' strong market positions and growth prospects in molecular diagnostics.
8 Sept, 08:12 — 8 Sept, 08:12
Sources
Showing 1 of 1 sources
